The positive rates of Beclin 1 were significantly higher in ovarian epithelial cancer and borderline tumor than in benign ovarian tumor or normal ovarian tissue (all p < 0.001; Table 1). This evidence concerns the gene BECN1 and ovarian carcinoma.